Drug Type Biosimilar, Monoclonal antibody |
Synonyms Adalimumab Biosimilar (PharmaPraxis), 阿达木单抗生物类似药(PharmaPraxis) |
Target |
Mechanism TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Crohn Disease | Preclinical | BR | 13 May 2011 | |
Psoriasis | Preclinical | BR | 13 May 2011 | |
Rheumatoid Arthritis | Preclinical | BR | 13 May 2011 |